# Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH

> **NCT02631421** · — · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 15 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **PROCEDURE:** Blood Sampling
- **OTHER:** Cardiac MRI

## Key facts

- **NCT ID:** NCT02631421
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631421, "Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02631421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*